Open access
Aug 2026
CSF p-tau205: a biomarker of Alzheimer's disease progression and biological staging.
CSF p-tau205 as a biomarker of Alzheimer's disease pathology and progression with potential value for biological staging is supported and when incorporated into a conceptual CSF-based staging model, the final p-tau205-positive stage showed the strongest association with cortical atrophy, cognitive impairment, and risk of progression to dementia.
J. Lantero-Rodríguez, S. Janelidze, S. Palmqvist et al.
· Molecular Psychiatry · 0 citations